Home > > > > > Report Detail

Wet Macular Degeneration - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Wet Macular Degeneration - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Wet Macular Degeneration epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Wet Macular Degeneration Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Wet Macular Degeneration in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Wet Macular Degeneration outlook. It also includes the explanation of changing trends of epidemiology outlining the Wet Macular Degeneration scenario.

Wet Macular Degeneration Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Wet Macular Degeneration thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Wet Macular Degeneration explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Wet Macular Degeneration Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Wet Macular Degeneration

Key assessments

- Patient Segmentation in Wet Macular Degeneration

- Wet Macular Degeneration Risk & Burden

- Factors driving growth in a specific Wet Macular Degeneration patient population

Wet Macular Degeneration - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Wet Macular Degeneration Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Wet Macular Degeneration in 2016
2.2. Patient Share Distribution of Wet Macular Degeneration in 2028
3. Disease Background and Overview: Wet Macular Degeneration
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Wet Macular Degeneration in 7MM
4.3. Total Prevalent/ Incident Patient Population of Wet Macular Degeneration in 7MM - By Countries
5. Epidemiology of Wet Macular Degeneration by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.1.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.1.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.1.5. Diagnosed Cases of the Wet Macular Degeneration
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.4.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.4.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.4.5. Diagnosed Cases of the Wet Macular Degeneration
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.5.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.5.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.5.5. Diagnosed Cases of the Wet Macular Degeneration
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.6.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.6.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.6.5. Diagnosed Cases of the Wet Macular Degeneration
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.7.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.7.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.7.5. Diagnosed Cases of the Wet Macular Degeneration
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.8.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.8.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.8.5. Diagnosed Cases of the Wet Macular Degeneration
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Wet Macular Degeneration
5.9.3. Sub-Type Specific cases of the Wet Macular Degeneration *
5.9.4. Sex- Specific Cases of the Wet Macular Degeneration *
5.9.5. Diagnosed Cases of the Wet Macular Degeneration
6. Unmet Needs of the Wet Macular Degeneration
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Wet Macular Degeneration in 7MM
Table 2: Total Prevalent/Incident Cases of the Wet Macular Degeneration in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Wet Macular Degeneration in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Wet Macular Degeneration in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Wet Macular Degeneration in United States (2016-2028)*
Table 6: Diagnosed Cases of the Wet Macular Degeneration in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Wet Macular Degeneration in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Wet Macular Degeneration in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Wet Macular Degeneration in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Wet Macular Degeneration in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Wet Macular Degeneration in France (2016-2028)
Table 12: Sub-Type Specific cases of the Wet Macular Degeneration in France (2016-2028) *
Table 13: Sex- Specific Cases of the Wet Macular Degeneration in France (2016-2028) *
Table 14: Diagnosed Cases of the Wet Macular Degeneration in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Wet Macular Degeneration in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Wet Macular Degeneration in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Wet Macular Degeneration in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Wet Macular Degeneration in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Wet Macular Degeneration in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Wet Macular Degeneration in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Wet Macular Degeneration in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Wet Macular Degeneration in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Wet Macular Degeneration in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Wet Macular Degeneration in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Wet Macular Degeneration in UK (2016-2028) *
Table 26: Diagnosed Cases of the Wet Macular Degeneration in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Wet Macular Degeneration in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Wet Macular Degeneration in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Wet Macular Degeneration in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Wet Macular Degeneration in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Wet Macular Degeneration in 7MM
Figure 2: Total Prevalent/Incident Cases of the Wet Macular Degeneration in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Wet Macular Degeneration in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Wet Macular Degeneration in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Wet Macular Degeneration in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Wet Macular Degeneration in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Wet Macular Degeneration in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Wet Macular Degeneration in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Wet Macular Degeneration in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Wet Macular Degeneration in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Wet Macular Degeneration in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Wet Macular Degeneration in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Wet Macular Degeneration in France (2016-2028) *
Figure 14: Diagnosed Cases of the Wet Macular Degeneration in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Wet Macular Degeneration in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Wet Macular Degeneration in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Wet Macular Degeneration in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Wet Macular Degeneration in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Wet Macular Degeneration in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Wet Macular Degeneration in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Wet Macular Degeneration in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Wet Macular Degeneration in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Wet Macular Degeneration in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Wet Macular Degeneration in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Wet Macular Degeneration in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Wet Macular Degeneration in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Wet Macular Degeneration in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Wet Macular Degeneration in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Wet Macular Degeneration in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Wet Macular Degeneration in Japan (2016-2028)

  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs